Clinical Trials Directory

Trials / Completed

CompletedNCT01409083

Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Children

Evaluating the Use of Intravenous Bicarbonate as a Tool to Verify the Intravascular Position of an IV Catheter in Children

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
2 Years – 8 Years
Healthy volunteers
Not accepted

Summary

Sodium bicarbonate injected into a blood vessel transforms to carbon dioxide and water. The increase in carbon dioxide production can be detected by measuring the exhaled carbon dioxide in the lungs. This study is conducted to access the clinical application of measuring exhaled carbon dioxide to verify the correct position of intravenous catheters.Once the catheter is in the correct position the injected bicarbonate will be detected as a distinct elevation of exhaled carbon dioxide. A similar study was already performed in adults and was found useful. The investigators now extend the clinical application to children.

Detailed description

Extravasation is the unintentional injection or leakage of fluids into the perivascular or subcutaneous space resulting in potential tissue injury. This prospective controlled study, will assesse the diagnostic utility of using intravenous diluted sodium bicarbonate to confirm placement of intravenous (IV) catheters in ventilated children. Diluted sodium bicarbonate will be created using undiluted standard 8.4% (1 meq/mL) sodium bicarbonate mixed in a 1:3 ratio with sterile water to achieve a final diluted concentration of 2.1% (0.25 mEq/mL). In 20 ASA I-II mechanically ventilated children age 2-8 years, the effects of 1 ml/kg of diluted 2.1% sodium bicarbonate or 0.9% normal saline,injected in a randomized order, will be analyzed. All children will have venous blood samples taken prior to injection and 10 minutes after injection for analysis of venous blood pH and electrolytes.

Conditions

Interventions

TypeNameDescription
DEVICEintravenous sodium bicarbonateDilted sodium bicarbonate 2.1%

Timeline

Start date
2011-07-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-08-03
Last updated
2012-12-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01409083. Inclusion in this directory is not an endorsement.